Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 36.02M
March 31, 2026 38.79M
December 31, 2025 47.52M
September 30, 2025 40.90M
June 30, 2025 39.11M
March 31, 2025 42.18M
December 31, 2024 54.62M
September 30, 2024 32.93M
June 30, 2024 52.01M
March 31, 2024 66.31M
December 31, 2023 81.60M
September 30, 2023 97.15M
June 30, 2023 62.20M
March 31, 2023 68.64M
December 31, 2022 44.72M
September 30, 2022 49.15M
June 30, 2022 63.44M
March 31, 2022 71.62M
Date Value
December 31, 2021 80.12M
September 30, 2021 88.76M
June 30, 2021 99.03M
March 31, 2021 108.10M
December 31, 2020 74.15M
September 30, 2020 80.38M
June 30, 2020 87.24M
March 31, 2020 94.44M
December 31, 2019 68.83M
September 30, 2019 76.07M
June 30, 2019 81.25M
March 31, 2019 85.98M
December 31, 2018 91.91M
September 30, 2018 98.80M
June 30, 2018 104.72M
March 31, 2018 29.40M
December 31, 2017 9.083M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics